APhA is offering an opportunity for you to participate in a unique and innovative project designed to help you develop a plan for expanding your pneumococcal immunization services. The project is being funded by an unrestricted educational grant from Pfizer Medical Education Group.
Applications for participation in the project are due September 15, 2013.
RxVaccinate is an educational project designed to provide pharmacists with the tools, resources, and training needed to initiate community-specific strategies to increase pneumococcal vaccination rates.
Application to participate in the project is open to any pharmacies with at least one staff member who has been trained to deliver immunizations through APhA's nationally recognized certificate training program, Pharmacy Based Immunization Delivery and are authorized by state regulations to administer pneumococcal immunizations.
There are several steps you must complete to become involved.
1. View the home study of a webinar titled, Pneumococcal Immunization Update. This webinar was presented on June 26, 2013 and provides an overview of the current CDC recommendations for pneumococcal immunizations and discuss the risks and benefits of pneumococcal immunization.
2. View the home study version of a webinar titled Expanding Pharmacy-Based Pneuococcal Immunization Services. This webinar was presented on August 8, 2013 and provides an introduction to tools and strategies for expanding pneumococcal immunization services, including evaluating current practice capability, community collaboration, marketing and reimbursement.
Both webinars are free and offer continuing pharmacy education (CPE) credits!
The American Pharmacists Association if accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).
3. Submit an application to be selected as either a control or intervention practice site. Applications will be reviewed to assign 50 pharmacies in each group that have similar practice site characteristics. All applications must be received by September 15, 2013.
4. Once all applications have been received, 100 pharmacy sites will be chosen for participation. If your pharmacy is selected for the intervention group, one pharmacist from your pharmacy must be designated to attend a live workshop on January 7, 2014 in Dallas (travel expenses reimbursed up to $750/participant). This workshop will help you use the tools introduced in the second webinar and develop an individualized plan for increasing immunization services in your specific practice setting! You will also receive continuing support and help in implementing this plan for the remainder of the study. If selected to the control group you will not be attending the workshop or receive on-going support beyond the webinar education study components.
Both the control and intervention pharmacies will be required to submit quarterly immunization progress reports and data to the study coordinator at the end of 2014. Each of the 100 pharmacy sites chosen for the study will receive a $1,000 stipend for participating.
For questions or more information, please contact Marcia Tomaselli at firstname.lastname@example.org or 202-429-4125